Auburn College of Veterinary Medicine
Clinical Trial for Canine Mammary Cancer
The College of Veterinary Medicine at Auburn University in Alabama is opening a clinical trial to evaluate the effectiveness of a new cellular therapeutic vaccine directed against mammary cancer in dogs.
Dogs can be spayed or intact with diagnosed or suspected multifocal mammary cancer and should be without radiographic evidence of disseminated metastatic disease (micro-metastases only).
They are looking for owners of such dogs to be identified for potential recruitment into the clinical trial prior to treatment. The treatment protocol lasts approximately 10-12 weeks followed by rechecks for the remainder of one year, and will be provided without charge for qualified enrollees. Referral from the owner’s personal Veterinarian or Veterinary Clinic is preferred.
To inquire regarding enrollment of patients, contact:
Annette Smith, DVM MS DACVIM – Oncology Service Director
Department of Clinical Services
R. Curtis Bird, PhD – Principle Investigator
Department of Pathobiology